Uppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink (OLK) ® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.

UPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel ...

UPPSALA, Sweden, May 04, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that its Olink® Explore 1536/384 platform is now available to researchers in Europe through the ...

Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay Thermo Fisher Scientific Inc., the world leader in serving science, today announced the ...

Biomarker selection for Olink Target 48 Immune Surveillance were designed to give researchers the most effective platform for detecting and quantifying up to 44 well-established biomarkers across key ...